Predictors of the Long-term Functional Benefits of a Pulmonary Rehabilitation Program?
NCT ID: NCT02528487
Last Updated: 2019-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
360 participants
OBSERVATIONAL
2015-05-31
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulmonary Rehabilitation at Home Versus at the Gymnasium
NCT00169897
Pulmonary Rehabilitation: Effects on Cognitive Functioning, Mood, Anxiety, and Quality of Life in Patients With COPD
NCT01682447
Effect of Pulmonary Telerehabilitation and Telemonitoring for Patients With Chronic Respiratory Diseases
NCT05824910
Status and Develepment Mental Quality of Life COPD/IPF Inpatients Before and After Pulmonary Rehabilitation
NCT03477526
Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study
NCT04658979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. they are diagnosed with moderate-severe COPD,
3. currently participate to a PR program, and
4. agree to participate.
Exclusion Criteria
1. they have any comorbidity that is more important (i.e., more likely to cause morbidity or mortality) than COPD (e.g., active cancer),
2. they have contraindications to exercise (though they will not likely be referred to PR),
3. they have participated in a PR program in the past year,
4. and if they are unable to provide informed consent due to language difficulties or cognitive impairment.
40 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mount Sinai Rehabilitation Hospital
OTHER
Hopital Charles Lemoyne
OTHER
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER
Jewish Rehabilitation Hospital
OTHER
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Grégory Moullec
Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Grégory Moullec, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jewish Rehabilitation Hospital
Laval, Quebec, Canada
Hopital Charles-Lemoyne
Longueuil, Quebec, Canada
Hopital du Sacre-Coeur de Montreal
Montreal, Quebec, Canada
Centre hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada
Mount-Sinai Hospital
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-1132 (MP)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.